Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8987262 | PIERRE FABRE DERMA | Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
Oct, 2028
(4 years from now) | |
US8338489 | PIERRE FABRE DERMA | Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
Oct, 2028
(4 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
Orphan Drug Exclusivity(ODE) | Mar 14, 2021 |
New Product(NP) | Mar 14, 2017 |
Orphan Drug Exclusivity(ODE-62) | Mar 14, 2021 |
Drugs and Companies using PROPRANOLOL HYDROCHLORIDE ingredient
Market Authorisation Date: 14 March, 2014
Treatment: Method to treat infantile hemangioma; Method to treat hemangioma.
Dosage: SOLUTION;ORAL